{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:59:49Z","timestamp":1792897189546,"version":"4.5.0"},"reference-count":127,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Bone Oncology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jbo.2024.100650","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T22:37:50Z","timestamp":1732055870000},"page":"100650","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Chinese expert consensus on the diagnosis and clinical management of medication-related osteonecrosis of the jaw"],"prefix":"10.1016","volume":"49","author":[{"given":"Han-Jin","family":"Ruan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Song","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Gang","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Xing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Song","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can-Hua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Fu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Qian","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Lin","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbo.2024.100650_b0005","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1038\/s41591-023-02655-3","article-title":"The landscape of cancer research and cancer care in China","volume":"29","author":"Lu","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.jbo.2024.100650_b0010","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1038\/s41591-024-03143-y","article-title":"Supervised, structured and individualized exercise in metastatic breast cancer: a randomized controlled trial","volume":"30","author":"Hiensch","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.jbo.2024.100650_b0015","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12885-017-3922-0","article-title":"Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States","volume":"18","author":"Hernandez","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jbo.2024.100650_b0020","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S2213-8587(24)00225-0","article-title":"Osteopenia: a key target for fracture prevention","volume":"12","author":"Reid","year":"2024","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.jbo.2024.100650_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2024.102828","article-title":"Bone complications of cancer treatment","volume":"130","author":"Zhu","year":"2024","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.jbo.2024.100650_b0030","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3390\/biomedicines8040095","article-title":"Does Medication-Related Osteonecrosis of the Jaw Influence the Quality of Life of Cancer Patients?","volume":"8","author":"Tenore","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.jbo.2024.100650_b0035","first-page":"474","article-title":"Research progress on treatment of medication-related osteonecrosis of the jaw","volume":"18","author":"Jiang","year":"2020","journal-title":"China Journal of Oral and Maxillofacial Surgery"},{"key":"10.1016\/j.jbo.2024.100650_b0040","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1200\/JCO.19.01186","article-title":"Medication-Related Osteonecrosis of the Jaw: MASCC\/ISOO\/ASCO Clinical Practice Guideline","volume":"37","author":"Yarom","year":"2019","journal-title":"JCO"},{"key":"10.1016\/j.jbo.2024.100650_b0045","doi-asserted-by":"crossref","unstructured":"Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons, American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws, J Oral Maxillofac Surg 65 (2007) 369\u2013376. doi: 10.1016\/j.joms.2006.11.003.","DOI":"10.1016\/j.joms.2006.11.003"},{"key":"10.1016\/j.jbo.2024.100650_b0050","first-page":"2","article-title":"American Association of Oral and Maxillofacial Surgeons, American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws\u20132009 update","volume":"67","author":"Ruggiero","year":"2009","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jbo.2024.100650_b0055","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons, American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20132014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jbo.2024.100650_b0060","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons\u2019 Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jbo.2024.100650_b0065","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jbo.2024.100650_b0070","first-page":"1391","article-title":"Canadian Association of Oral and Maxillofacial Surgeons, Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw","volume":"35","author":"Khan","year":"2008","journal-title":"J Rheumatol."},{"key":"10.1016\/j.jbo.2024.100650_b0075","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S1470-2045(18)30072-X","article-title":"Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study","volume":"19","author":"Raje","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jbo.2024.100650_b0080","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S2213-8587(17)30138-9","article-title":"10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension","volume":"5","author":"Bone","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.jbo.2024.100650_b0085","unstructured":"Z. Zhang, Oral and Maxillofacial Surgery, in: People\u2019s Medical Publishing House, 2020: p. 130."},{"key":"10.1016\/j.jbo.2024.100650_b0090","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrclinonc.2011.197","article-title":"Denosumab in patients with cancer-a surgical strike against the osteoclast","volume":"9","author":"Brown","year":"2012","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jbo.2024.100650_b0095","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1056\/NEJMoa0802633","article-title":"Giant osteoclast formation and long-term oral bisphosphonate therapy","volume":"360","author":"Weinstein","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbo.2024.100650_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114669","article-title":"Parathyroid hormone and its related peptides in bone metabolism","volume":"192","author":"Chen","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jbo.2024.100650_b0105","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMc1002684","article-title":"Teriparatide therapy for alendronate-associated osteonecrosis of the jaw","volume":"363","author":"Cheung","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbo.2024.100650_b0110","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1200\/JCO.19.02192","article-title":"Teriparatide Promotes Bone Healing in Medication-Related Osteonecrosis of the Jaw: A Placebo-Controlled, Randomized Trial","volume":"38","author":"Sim","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jbo.2024.100650_b0115","doi-asserted-by":"crossref","first-page":"6648","DOI":"10.3390\/ijms25126648","article-title":"Local E-rhBMP-2\/\u03b2-TCP Application Rescues Osteocyte Dendritic Integrity and Reduces Microstructural Damage in Alveolar Bone Post-Extraction in MRONJ-like Mouse Model","volume":"25","author":"Dang","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.jbo.2024.100650_b0120","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1002\/jbmr.3237","article-title":"Short-Term Teriparatide and Recombinant Human Bone Morphogenetic Protein-2 for Regenerative Approach to Medication-Related Osteonecrosis of the Jaw: A Preliminary Study","volume":"32","author":"Jung","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.jbo.2024.100650_b0125","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/annonc\/mdi206","article-title":"Jaw avascular bone necrosis associated with long-term use of biphosphonates","volume":"16","author":"Sanna","year":"2005","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jbo.2024.100650_b0130","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41580-020-00279-w","article-title":"Mechanisms of bone development and repair","volume":"21","author":"Salhotra","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jbo.2024.100650_b0135","doi-asserted-by":"crossref","unstructured":"X. Shen, W. Zhu, P. Zhang, Y. Fu, J. Cheng, L. Liu, R. Xu, H. Jiang, Macrophage miR-149-5p induction is a key driver and therapeutic target for BRONJ, JCI Insight 7 (n.d.) e159865. doi: 10.1172\/jci.insight.159865.","DOI":"10.1172\/jci.insight.159865"},{"key":"10.1016\/j.jbo.2024.100650_b0140","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1620\/tjem.248.27","article-title":"Antiresorptive Agents and Anti-Angiogenesis Drugs in the Development of Osteonecrosis of the Jaw","volume":"248","author":"Allegra","year":"2019","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.jbo.2024.100650_b0145","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/jbmr.1769","article-title":"Can peripheral blood \u03b3\u03b4 T cells predict osteonecrosis of the jaw? An Immunological Perspective on the Adverse Drug Effects of Aminobisphosphonate Therapy","volume":"28","author":"Kalyan","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbo.2024.100650_b0150","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.5037\/jomr.2016.7403","article-title":"Microscopic Evaluation of the Effect of Oral Microbiota on the Development of Bisphosphonate-Related Osteonecrosis of the Jaws in Rats","volume":"7","author":"Silveira","year":"2016","journal-title":"J Oral Maxillofac Res"},{"key":"10.1016\/j.jbo.2024.100650_b0155","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/0022034517732770","article-title":"Zoledronate Impairs Socket Healing after Extraction of Teeth with Experimental Periodontitis","volume":"97","author":"Soundia","year":"2018","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.jbo.2024.100650_b0160","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.joms.2018.08.010","article-title":"Development of Medication-Related Osteonecrosis of the Jaw After Extraction of Teeth With Experimental Periapical Disease","volume":"77","author":"Hadaya","year":"2019","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jbo.2024.100650_b0165","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.jcms.2016.09.018","article-title":"Clinical features of peri-implant medication-related osteonecrosis of the jaw: Is there an association to peri-implantitis?","volume":"44","author":"Troeltzsch","year":"2016","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.jbo.2024.100650_b0170","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/annonc\/mdr039","article-title":"Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: a single-center clinical experience","volume":"23","author":"Vandone","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jbo.2024.100650_b0175","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jormas.2020.07.012","article-title":"Actinomyces and MRONJ: A retrospective study and a literature review","volume":"122","author":"Cerrato","year":"2021","journal-title":"J Stomatol Oral Maxillofac Surg"},{"key":"10.1016\/j.jbo.2024.100650_b0180","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1177\/0022034520908594","article-title":"Indigenous microbiota protects against inflammation-induced osteonecrosis","volume":"99","author":"Williams","year":"2020","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.jbo.2024.100650_b0185","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/0022034514560768","article-title":"Diabetes as a risk factor for medication-related osteonecrosis of the jaw","volume":"94","author":"Peer","year":"2015","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.jbo.2024.100650_b0190","doi-asserted-by":"crossref","first-page":"20743","DOI":"10.18632\/aging.104006","article-title":"Determination of the molecular mechanism by which macrophages and \u03b3\u03b4-T cells contribute to ZOL-induced ONJ","volume":"12","author":"Qu","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.jbo.2024.100650_b0195","article-title":"The Role of the Immune Response in the Development of Medication-Related Osteonecrosis of the Jaw","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jbo.2024.100650_b0200","doi-asserted-by":"crossref","DOI":"10.1177\/2309499020915989","article-title":"Incidence, prevalence, and outcomes of systemic malignancy with bone metastases","volume":"28","author":"Jiang","year":"2020","journal-title":"J. Orthop. Surg. (Hong Kong)"},{"key":"10.1016\/j.jbo.2024.100650_b0205","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41572-020-00216-3","article-title":"Bone metastases","volume":"6","author":"Coleman","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jbo.2024.100650_b0210","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/jbmr.3618","article-title":"Understanding the Bone in Cancer Metastasis","volume":"33","author":"Fornetti","year":"2018","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.jbo.2024.100650_b0215","doi-asserted-by":"crossref","first-page":"482","DOI":"10.21037\/atm.2020.03.55","article-title":"Incidence of patients with bone metastases at diagnosis of solid tumors in adults: a large population-based study","volume":"8","author":"Huang","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jbo.2024.100650_b0220","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.otorri.2014.06.003","article-title":"Epidemiology, pharmacology and clinical characterization of bisphosphonate-related osteonecrosis of the jaw. A retrospective study of 70 cases","volume":"66","author":"Pelaz","year":"2015","journal-title":"Acta Otorrinolaringol. Esp."},{"key":"10.1016\/j.jbo.2024.100650_b0225","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ijom.2014.08.011","article-title":"Lipopolysaccharide aggravates bisphosphonate-induced osteonecrosis in rats","volume":"44","author":"Sakaguchi","year":"2015","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jbo.2024.100650_b0230","doi-asserted-by":"crossref","first-page":"JCO2400171","DOI":"10.1200\/JCO.24.00171","article-title":"Incidence of Medication-Related Osteonecrosis of the Jaw in Patients With Breast Cancer During a 20-Year Follow-Up: A Population-Based Multicenter Retrospective Study","author":"Brunner","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jbo.2024.100650_b0235","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/clr.12556","article-title":"Denosumab and osteonecrosis of the jaw. A Systematic Analysis of Events Reported in Clinical Trials","volume":"27","author":"Boquete-Castro","year":"2016","journal-title":"Clin Oral Implants Res"},{"key":"10.1016\/j.jbo.2024.100650_b0240","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1007\/s00520-014-2251-y","article-title":"Patients with bone metastases from solid tumors initiating treatment with a bone-targeted agent in 2011: a descriptive analysis using oncology clinic data in the US","volume":"22","author":"Hernandez","year":"2014","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.jbo.2024.100650_b0245","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000201931","article-title":"Combination of bisphosphonates and antiangiogenic factors induces osteonecrosis of the jaw more frequently than bisphosphonates alone","volume":"76","author":"Christodoulou","year":"2009","journal-title":"Oncology"},{"key":"10.1016\/j.jbo.2024.100650_b0250","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10549-010-0866-3","article-title":"Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer","volume":"122","author":"Guarneri","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.jbo.2024.100650_bib562","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10549-011-1429-y","article-title":"Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01\u201304) for women with stage II\/III breast cancer","volume":"127","author":"Coleman","year":"2011","journal-title":"Breast cancer research and treatment"},{"key":"10.1016\/j.jbo.2024.100650_bib563","first-page":"2985","article-title":"Bisphosphonates in the treatment of patients with lung cancer and metastatic bone disease: a systematic review and meta-analysis. Supportive Care\u00a0 Cancer","volume":"20","author":"Lopez-Olivo","year":"2012"},{"key":"10.1016\/j.jbo.2024.100650_bib564","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10549-009-0432-z","article-title":"Osteonecrosis of the jaw and use of bisphosphonates in adjuvant breast cancer treatment: a meta-analysis","volume":"116","author":"Mauri","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jbo.2024.100650_b0255","article-title":"Interventions for managing medication-related osteonecrosis of the jaw","volume":"7","author":"Nh","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jbo.2024.100650_b0260","first-page":"CD012432","article-title":"Interventions for managing medication-related osteonecrosis of the jaw","volume":"10","author":"Beth-Tasdogan","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jbo.2024.100650_b0265","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.14219\/jada.archive.2010.0082","article-title":"The incidence of osteonecrosis of the jaw in patients receiving 5 milligrams of zoledronic acid: data from the health outcomes and reduced incidence with zoledronic acid once yearly clinical trials program","volume":"141","author":"Grbic","year":"2010","journal-title":"J. Am. Dent. Assoc."},{"key":"10.1016\/j.jbo.2024.100650_b0270","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.oooo.2022.04.049","article-title":"A comparative study of the clinical characteristics of patients with medication-related osteonecrosis of the jaw and osteoporosis or malignancy, Oral Surg Oral Med Oral Pathol","volume":"134","author":"Feng","year":"2022","journal-title":"Oral Radiol."},{"key":"10.1016\/j.jbo.2024.100650_b0275","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1007\/s00520-022-06839-4","article-title":"Prognosis by cancer type and incidence of zoledronic acid-related osteonecrosis of the jaw: a single-center retrospective study","volume":"30","author":"Hata","year":"2022","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.jbo.2024.100650_b0280","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/odi.12632","article-title":"GENVABO Consortium, S. Fedele, Time to Onset of Bisphosphonate-Related Osteonecrosis of the Jaws: a Multicentre Retrospective Cohort Study","volume":"23","author":"Fung","year":"2017","journal-title":"Oral Dis"},{"key":"10.1016\/j.jbo.2024.100650_bib565","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00520-020-05556-0","article-title":"Long-term impact of bone-modifying agents for the treatment of bone metastases: a systematic review","volume":"29","author":"Ng","year":"2021","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jbo.2024.100650_bib566","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/j.joms.2021.07.029","article-title":"Recurrence-Related Factors of Medication-Related Osteonecrosis of the Jaw: A Five-Year Experience","volume":"79","author":"Chen","year":"2021","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jbo.2024.100650_b0285","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","article-title":"Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases","volume":"23","author":"Saad","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jbo.2024.100650_b0290","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/odi.12708","article-title":"Risk factors for medication-related osteonecrosis of the jaws: A systematic review","volume":"24","author":"McGowan","year":"2018","journal-title":"Oral Dis."},{"key":"10.1016\/j.jbo.2024.100650_b0295","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.joms.2013.02.016","article-title":"Oral health risk factors for bisphosphonate-associated jaw osteonecrosis","volume":"71","author":"Tsao","year":"2013","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jbo.2024.100650_b0300","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.joms.2020.12.045","article-title":"Factors Influencing Severity of Medication-Related Osteonecrosis of the Jaw: a Retrospective Study","volume":"79","author":"Feng","year":"2021","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jbo.2024.100650_b0305","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.oooo.2018.08.015","article-title":"Prevalence, initiating factor, and treatment outcome of medication-related osteonecrosis of the jaw-a 4-year prospective study, Oral Surg Oral Med Oral Pathol","volume":"126","author":"Hallmer","year":"2018","journal-title":"Oral Radiol."},{"key":"10.1016\/j.jbo.2024.100650_b0310","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.jcms.2017.05.028","article-title":"What is the effect of anti-resorptive drugs (ARDs) on the development of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: a systematic review","volume":"45","author":"Aljohani","year":"2017","journal-title":"J. Craniomaxillofac. Surg."},{"key":"10.1016\/j.jbo.2024.100650_b0315","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1210\/jc.2018-01965","article-title":"Invasive Oral Procedures and Events in Postmenopausal Women With Osteoporosis Treated With Denosumab for Up to 10 Years","volume":"104","author":"Watts","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jbo.2024.100650_b0320","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.3390\/jcm11071807","article-title":"Minimizing MRONJ after Tooth Extraction in Cancer Patients Receiving Bone-Modifying Agents","volume":"11","author":"Avishai","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jbo.2024.100650_b0325","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00198-018-4746-8","article-title":"Japanese Study Group of Co-operative Dentistry with Medicine (JCDM), Medication-related osteonecrosis of the jaw after tooth extraction in cancer patients: a multicenter retrospective study","volume":"30","author":"Hasegawa","year":"2019","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.jbo.2024.100650_b0330","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1200\/JCO.2008.16.2768","article-title":"Bisphosphonate-related osteonecrosis of the jaws: a case-control study of risk factors in breast cancer patients","volume":"26","author":"Kyrgidis","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jbo.2024.100650_b0335","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1200\/JCO.2009.21.9584","article-title":"Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw","volume":"27","author":"Vahtsevanos","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jbo.2024.100650_b0340","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.ijom.2012.06.020","article-title":"Increased incidence of osteonecrosis of the jaw after tooth extraction in patients treated with bisphosphonates: a cohort study","volume":"41","author":"Yamazaki","year":"2012","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jbo.2024.100650_b0345","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10147-013-0561-6","article-title":"Risk of osteonecrosis of the jaw in cancer patients receiving denosumab: a meta-analysis of seven randomized controlled trials","volume":"19","author":"Qi","year":"2014","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.jbo.2024.100650_b0350","first-page":"237","article-title":"Research Progress on Medication-Related Osteonecrosis of the Jaw","volume":"33","author":"Zhou","year":"2019","journal-title":"Journal of Modern Stomatology"},{"key":"10.1016\/j.jbo.2024.100650_b0355","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4103\/0975-5950.127643","article-title":"Bisphophonates related osteonecrosis of the jaw, Natl","volume":"4","author":"Gupta","year":"2013","journal-title":"J. Maxillofac. Surg."},{"key":"10.1016\/j.jbo.2024.100650_b0360","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.joms.2008.12.002","article-title":"Imaging findings in bisphosphonate-related osteonecrosis of jaws","volume":"67","author":"Arce","year":"2009","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"8","key":"10.1016\/j.jbo.2024.100650_bib567","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jcms.2016.05.013","article-title":"Metastatic solid tumors to the jaw and oral soft tissue: A retrospective clinical analysis of 44 patients from a single institution","volume":"44","author":"Owosho","year":"2016","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.jbo.2024.100650_bib568","first-page":"104","article-title":"Clinical analysis of metastatic carcinoma of the jaws China Continuing","volume":"8","author":"He","year":"2016","journal-title":"China Continuing Medical Education"},{"key":"10.1016\/j.jbo.2024.100650_bib574","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1111\/odi.13968","article-title":"Bacterial spectrum analysis and antimicrobial susceptibility study of osteoradionecrosis of the jaw in Southern China","volume":"28","author":"Zhu","year":"2022","journal-title":"Oral Dis"},{"key":"10.1016\/j.jbo.2024.100650_bib575","doi-asserted-by":"crossref","first-page":"1851112","DOI":"10.1080\/20002297.2020.1851112","article-title":"Treponema, and Mogibacterium promote IL8\/IFN\u03b3\/TNF\u03b1-based pro-inflammation in patients with medication-related osteonecrosis of the jaw","volume":"13","author":"Li","year":"2020","journal-title":"J Oral Microbiol"},{"key":"10.1016\/j.jbo.2024.100650_b0365","doi-asserted-by":"crossref","first-page":"151","DOI":"10.11005\/jbm.2015.22.4.151","article-title":"Medication Related Osteonecrosis of the Jaw: 2015 Position Statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons","volume":"22","author":"Kim","year":"2015","journal-title":"J Bone Metab"},{"key":"10.1016\/j.jbo.2024.100650_b0370","doi-asserted-by":"crossref","unstructured":"Japanese Allied Committee on Osteonecrosis of the Jaw, T. Yoneda, H. Hagino, T. Sugimoto, H. Ohta, S. Takahashi, S. Soen, A. Taguchi, T. Nagata, M. Urade, T. Shibahara, S. Toyosawa, Antiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw, J Bone Miner Metab 35 (2017) 6\u201319. doi: 10.1007\/s00774-016-0810-7.","DOI":"10.1007\/s00774-016-0810-7"},{"key":"10.1016\/j.jbo.2024.100650_b0375","doi-asserted-by":"crossref","DOI":"10.1007\/s11657-020-00761-0","article-title":"Therapeutic approach and management algorithms in medication-related osteonecrosis of the jaw (MONJ): recommendations of a multidisciplinary group of experts","volume":"15","author":"Chalem","year":"2020","journal-title":"Arch. Osteoporos."},{"key":"10.1016\/j.jbo.2024.100650_b0380","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1111\/odi.14887","article-title":"Italian position paper (SIPMO-SICMF) on medication-related osteonecrosis of the jaw (MRONJ)","volume":"30","author":"Bedogni","year":"2024","journal-title":"Oral Dis."},{"key":"10.1016\/j.jbo.2024.100650_b0385","first-page":"501","article-title":"A New Clinical Staging and Treatment Strategy for Medication-Related Osteonecrosis of the Jaw, Chinese","volume":"18","author":"Liu","year":"2020","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jbo.2024.100650_b0390","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1601-0825.2011.01848.x","article-title":"Antibiotic effects on bacterial profile in osteonecrosis of the jaw","volume":"18","author":"Ji","year":"2012","journal-title":"Oral Dis"},{"issue":"181\u2013203","key":"10.1016\/j.jbo.2024.100650_b0395","first-page":"204","article-title":"Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) therapy. A Critical Review","volume":"59","author":"Vescovi","year":"2010","journal-title":"Minerva Stomatol"},{"key":"10.1016\/j.jbo.2024.100650_b0400","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.joms.2010.06.200","article-title":"Relevance of a prolonged preoperative antibiotic regime in the treatment of bisphosphonate-related osteonecrosis of the jaw","volume":"69","author":"Hoefert","year":"2011","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jbo.2024.100650_b0405","first-page":"33","article-title":"Bisphosphonate-related osteonecrosis of the jaws: a potential alternative to drug holidays","volume":"61","author":"Damm","year":"2013","journal-title":"Gen. Dent."},{"issue":"2009","key":"10.1016\/j.jbo.2024.100650_b0410","first-page":"662","article-title":"Two faces of nitric oxide: implications for cellular mechanisms of oxygen toxicity","volume":"106","author":"Allen","year":"1985","journal-title":"J. Appl. Physiol."},{"issue":"1990","key":"10.1016\/j.jbo.2024.100650_b0415","first-page":"1761","article-title":"Regional H2O2 concentration in rat brain after hyperoxic convulsions","volume":"69","author":"Piantadosi","year":"1985","journal-title":"J. Appl. Physiol."},{"issue":"2000","key":"10.1016\/j.jbo.2024.100650_b0420","first-page":"1381","article-title":"Nitric oxide and cerebral blood flow responses to hyperbaric oxygen","volume":"88","author":"Demchenko","year":"1985","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.jbo.2024.100650_b0425","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0006-8993(01)03057-8","article-title":"Nitric oxide production is enhanced in rat brain before oxygen-induced convulsions","volume":"917","author":"Demchenko","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.jbo.2024.100650_b0430","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.joms.2008.12.003","article-title":"Utility of hyperbaric oxygen in treatment of bisphosphonate-related osteonecrosis of the jaws","volume":"67","author":"Freiberger","year":"2009","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jbo.2024.100650_b0435","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.joms.2012.04.001","article-title":"What is the role of hyperbaric oxygen in the management of bisphosphonate-related osteonecrosis of the jaw: a randomized controlled trial of hyperbaric oxygen as an adjunct to surgery and antibiotics","volume":"70","author":"Freiberger","year":"2012","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jbo.2024.100650_b0440","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.tripleo.2010.05.067","article-title":"Management of bisphosphonate-associated osteonecrosis: pentoxifylline and tocopherol in addition to antimicrobial therapy. An Initial Case Series","volume":"110","author":"Epstein","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.jbo.2024.100650_b0445","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.joms.2013.06.188","article-title":"Pentoxifylline and tocopherol in the treatment of yearly zoledronic acid-related osteonecrosis of the jaw in a corticosteroid-induced osteoporosis","volume":"72","author":"Magremanne","year":"2014","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jbo.2024.100650_b0450","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.ijom.2013.05.001","article-title":"The effects of adjunctive parathyroid hormone injection on bisphosphonate-related osteonecrosis of the jaws: an animal study","volume":"42","author":"Dayisoylu","year":"2013","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jbo.2024.100650_b0455","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s00198-014-2622-8","article-title":"Distinctive role of 6-month teriparatide treatment on intractable bisphosphonate-related osteonecrosis of the jaw","volume":"25","author":"Kim","year":"2014","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.jbo.2024.100650_b0460","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.ijom.2015.07.018","article-title":"Administration of teriparatide improves the symptoms of advanced bisphosphonate-related osteonecrosis of the jaw: preliminary findings","volume":"44","author":"Kakehashi","year":"2015","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jbo.2024.100650_b0465","doi-asserted-by":"crossref","DOI":"10.1111\/odi.15006","article-title":"Reduction of MRONJ risk after exodontia by virtue of ozone infiltration: A randomized clinical trial","author":"Di Fede","year":"2024","journal-title":"Oral Dis."},{"key":"10.1016\/j.jbo.2024.100650_b0470","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s10006-024-01246-x","article-title":"Ozone infiltration as an adjunctive treatment to piezoelectric surgery in the management of medication-related osteonecrosis of the jaws: case series of 29 patients","volume":"28","author":"Goker","year":"2024","journal-title":"Oral Maxillofac. Surg."},{"key":"10.1016\/j.jbo.2024.100650_b0475","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00784-024-05547-z","article-title":"Ozone therapy effect in medication-related osteonecrosis of the jaw as prevention or treatment: microtomographic, confocal laser microscopy and histomorphometric analysis","volume":"28","author":"Pereira-Silva","year":"2024","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.jbo.2024.100650_b0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2020.101651","article-title":"Antimicrobial photodynamic and photobiomodulation adjuvant therapies for prevention and treatment of medication-related osteonecrosis of the jaws: Case series and long-term follow-up","volume":"29","author":"Tartaroti","year":"2020","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"10.1016\/j.jbo.2024.100650_b0485","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.oraloncology.2011.08.010","article-title":"Association of laser phototherapy with PRP improves healing of bisphosphonate-related osteonecrosis of the jaws in cancer patients: a preliminary study","volume":"48","author":"Martins","year":"2012","journal-title":"Oral Oncol."},{"key":"10.1016\/j.jbo.2024.100650_b0490","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1089\/pho.2009.2501","article-title":"Effect of low-level laser irradiation on bisphosphonate-induced osteonecrosis of the jaws: preliminary results of a prospective study","volume":"28","author":"Scoletta","year":"2010","journal-title":"Photomed. Laser Surg."},{"key":"10.1016\/j.jbo.2024.100650_b0495","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/pho.2010.2955","article-title":"Early surgical laser-assisted management of bisphosphonate-related osteonecrosis of the jaws (BRONJ): a retrospective analysis of 101 treated sites with long-term follow-up","volume":"30","author":"Vescovi","year":"2012","journal-title":"Photomed. Laser Surg."},{"key":"10.1016\/j.jbo.2024.100650_bib569","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.oraloncology.2011.12.004","article-title":"Platelet-rich therapies in the treatment of intravenous bisphosphonate-related osteonecrosis of the jaw: a report of 32 cases","volume":"48","author":"Mozzati","year":"2012","journal-title":"Oral Oncol"},{"key":"10.1016\/j.jbo.2024.100650_bib570","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.bjoms.2014.07.256","article-title":"Leucocyte-rich and platelet-rich fibrin for the treatment of bisphosphonate-related osteonecrosis of the jaw: a prospective feasibility study","volume":"52","author":"Kim","year":"2014","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.jbo.2024.100650_bib571","first-page":"961","article-title":"Clinical and histopathological studies using fibrin-rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw","volume":"55","author":"Dinc\u0103","year":"2014","journal-title":"Rom. J Morphol. Embryol."},{"key":"10.1016\/j.jbo.2024.100650_bib572","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.ijom.2016.04.010","article-title":"Surgical treatment of osteonecrosis of the jaw with the use of platelet-rich fibrin: a prospective study of 15 patients","volume":"45","author":"N\u00f8rholt","year":"2016","journal-title":"Int. J Oral Maxillofac. Surg."},{"key":"10.1016\/j.jbo.2024.100650_bib573","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.joms.2016.12.005","article-title":"Does the Addition of Bone Morphogenetic Protein 2 to Platelet-Rich Fibrin Improve Healing After Treatment for Medication-Related Osteonecrosis of the Jaw?","volume":"75","author":"Park","year":"2017","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jbo.2024.100650_b0500","doi-asserted-by":"crossref","first-page":"20170323","DOI":"10.1259\/dmfr.20170323","article-title":"CT imaging features of antiresorptive agent-related osteonecrosis of the jaw\/medication-related osteonecrosis of the jaw","volume":"47","author":"Baba","year":"2018","journal-title":"Dentomaxillofac. Radiol."},{"key":"10.1016\/j.jbo.2024.100650_b0505","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.oooo.2016.03.015","article-title":"A technique for the treatment of oral-antral fistulas resulting from medication-related osteonecrosis of the maxilla: the combined buccal fat pad flap and radical sinusotomy, Oral Surg Oral Med Oral Pathol","volume":"122","author":"Melville","year":"2016","journal-title":"Oral Radiol."},{"key":"10.1016\/j.jbo.2024.100650_b0510","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/odi.12992","article-title":"Surgical treatment of medication-related osteonecrosis of the upper jaw: Case series","volume":"25","author":"Aljohani","year":"2019","journal-title":"Oral Dis."},{"key":"10.1016\/j.jbo.2024.100650_bib561","first-page":"447","article-title":"Effect of the surgical treatment of maxillary medication-related osteonecrosis of the jaw","volume":"56","author":"Tian","year":"2021","journal-title":"Chinese Journal of Stomatology"},{"key":"10.1016\/j.jbo.2024.100650_b0515","first-page":"441","article-title":"Application of the submandibular gland for management of stage 3 medication-related osteonecrosis of the mandible","volume":"56","author":"An","year":"2021","journal-title":"Zhonghua Kou Qiang Yi Xue Za Zhi"},{"key":"10.1016\/j.jbo.2024.100650_b0520","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.joms.2009.01.006","article-title":"The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws","volume":"67","author":"Carlson","year":"2009","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jbo.2024.100650_b0525","doi-asserted-by":"crossref","first-page":"20160065","DOI":"10.1259\/dmfr.20160065","article-title":"Can dental panoramic radiographic findings serve as indicators for the development of medication-related osteonecrosis of the jaw?","volume":"45","author":"Klingelh\u00f6ffer","year":"2016","journal-title":"Dentomaxillofac. Radiol."},{"key":"10.1016\/j.jbo.2024.100650_b0530","first-page":"128","article-title":"Interpretation of medication-related osteonecrosis of the jaw: MASCC\/ISOO\/ASCO clinical practice guideline","volume":"57","author":"Chen","year":"2022","journal-title":"Zhonghua Kou Qiang Yi Xue Za Zhi"},{"key":"10.1016\/j.jbo.2024.100650_b0535","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/s00520-021-06587-x","article-title":"A retrospective study on the incidence of medication-related osteonecrosis of the jaws (MRONJ) associated with different preventive dental care modalities","volume":"30","author":"Bacci","year":"2022","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.jbo.2024.100650_b0540","doi-asserted-by":"crossref","first-page":"6429","DOI":"10.1007\/s00520-022-06940-8","article-title":"The preventive care of medication-related osteonecrosis of the jaw (MRONJ): a position paper by Italian experts for dental hygienists","volume":"30","author":"Mauceri","year":"2022","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.jbo.2024.100650_b0545","first-page":"61","article-title":"Clinical application of double-layer soft tissue closure technology based on pedicled buccal fat pad in repairing maxillary defects after medication-related osteonecrosis of jaw surgery","volume":"40","author":"Guo","year":"2022","journal-title":"Hua Xi Kou Qiang Yi Xue Za Zhi"},{"key":"10.1016\/j.jbo.2024.100650_b0550","first-page":"2684924","article-title":"The Dental Management of Patients at Risk of Medication-Related Osteonecrosis of the Jaw: New Paradigm of Primary Prevention","author":"Di Fede","year":"2018","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.jbo.2024.100650_b0555","first-page":"63","article-title":"The Prevention of Medication-related Osteonecrosis of the Jaw","volume":"114","author":"Poxleitner","year":"2017","journal-title":"Dtsch. Arztebl. Int."},{"key":"10.1016\/j.jbo.2024.100650_b0560","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1007\/s00784-018-2655-z","article-title":"Microbial diversity in infections of patients with medication-related osteonecrosis of the jaw","volume":"23","author":"Zirk","year":"2019","journal-title":"Clin. Oral Invest."}],"container-title":["Journal of Bone Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137424001301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137424001301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T01:20:40Z","timestamp":1733534440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212137424001301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":127,"alternative-id":["S2212137424001301"],"URL":"https:\/\/doi.org\/10.1016\/j.jbo.2024.100650","relation":{},"ISSN":["2212-1374"],"issn-type":[{"value":"2212-1374","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chinese expert consensus on the diagnosis and clinical management of medication-related osteonecrosis of the jaw","name":"articletitle","label":"Article Title"},{"value":"Journal of Bone Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbo.2024.100650","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"100650"}}